AMPK mediates the initiation of kidney disease induced by a high-fat diet

Journal of the American Society of Nephrology

Volumn 22, Issue 10, 2011, Pages 1846-1855

  Declèves, Anne Emilie ^a,b   Mathew, Anna V ^a,b   Cunard, Robyn ^a,b   Sharma, Kumar ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; HYDROGEN PEROXIDE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; LIPID DIET; MOUSE; NEPHRITIS; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 80053497734     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011010026     Document Type: Article

References (36)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-1555, 2006
2. Bruce KD, Byrne CD: The metabolic syndrome: Common origins of a multifactorial disorder. Postgrad Med J 85: 614-621, 2009
3. Praga M, Morales E: Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 15: 481-486, 2006
4. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ: Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int 73: 19-33, 2008 (Pubitemid 350273639)
5. Kincaid-Smith P: Hypothesis: Obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'. J Hypertens 22: 1051-1055, 2004
6. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006 (Pubitemid 46780716)
7. Pai R, Kirschenbaum MA, Kamanna VS: Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells. Kidney Int 48: 1254-1262, 1995
8. Coimbra TM, Janssen U, Gröne HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, Floege J: Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 57: 167-182, 2000 (Pubitemid 30227764)
9. Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, Li L: Obesity-related glomerulopathy: Insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 147: 44-50, 2006 (Pubitemid 43004261)
10. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M, Kashiwagi A, Uzu T: Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am. J Physiol Renal Physiol. 296: F118-F126, 2009
11. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ: Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118: 1645-1656, 2008 (Pubitemid 351632369)
12. Steinberg GR, Kemp BE: AMPK in Health and disease. Physiol Rev 89: 1025-1078, 2009
13. Liu Y, Wan Q, Guan Q, Gao L, Zhao J: High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle. Biochem Biophys Res Commun 339: 701-707, 2006 (Pubitemid 41739724)
14. Motawi TM, Hashem RM, Rashed LA, El-Razek SM: Comparative study between the effect of the peroxisome proliferator activated receptor-a ligands fenofibrate and n-3 polyunsaturated fatty acids on activation of 5′-AMP-activated protein kinase-a1 in high-fat fed rats. J Pharm Pharmacol 61: 1339-1346, 2009
15. Lin J, Judd S, Le A, Ard J, Newsome BB, Howard G, Warnock DG, McClellan W: Associations of dietary fat with albuminuria and kidney dysfunction. Am J Clin Nutr 92: 897-904, 2010
16. Ruan X, Guan Y: Metabolic syndrome and chronic kidney disease. J Diabetes 1: 236-245, 2009
17. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, Kemp BE: Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271: 611-614, 1996 (Pubitemid 26034902)
18. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003 (Pubitemid 36735700)
19. Carling D: The AMP-activated protein kinase cascade - A unifying system for energy control. Trends Biochem Sci 29: 18-24, 2004
20. Hardie DG, Hawley SA, Scott JW: AMP-activated protein kinase development of the energy sensor concept. J Physiol 574: 7-15, 2006 (Pubitemid 43905792)
21. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D: Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2: 31-33, 2005
22. Kume S, Uzu T, Araki S, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Kubota N, Terauchi Y, Kadowaki T, Haneda M, Kashiwagi A, Koya D: Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 18: 2715-2723, 2007. (Pubitemid 47531198)
23. Corton JM, Gillespie JG, Hawley SA, Hardie DG: 5-Aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells. Eur J Biochem 229: 558-565, 1995
24. Lihn AS, Jessen N, Pedersen SB, Lund S, Richelsen B: AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem Biophys Res Commun 316: 853-858, 2004 (Pubitemid 38368031)
25. Peairs A, Radjavi A, Davis S, Li L, Ahmed A, Giri S, Reilly CM: Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells. Clin Exp Immunol 156: 542-551, 2009
26. Furuichi K, Kaneko S, Wada T: Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease. Clin Exp Nephrol 13: 9-14, 2009
27. Eardley KS, Kubal C, Zehnder D, Quinkler M, Lepenies J, Savage CO, Howie AJ, Kaur K, Cooper MS, Adu D, Cockwell P: The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int 74: 495-504, 2008
28. Tarabra E, Giunti S, Barutta F, Salvidio G, Burt D, Deferrari G, Gambino R, Vergola D, Pinach S, Perin PC, Camussi G, Gruden G: Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes. Diabetes 58: 2109-2118, 2009
29. Weisberg SP, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K, Charo I, Leibel RL, Ferrante AW Jr: CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 116: 115-124, 2006 (Pubitemid 43121796)
30. Kirk EA, Sagawa ZK, McDonald TO, O'Brien KD, Heinecke JW: Monocyte chemoattractant protein deficiency fails to restrain macrophage infiltration into adipose tissue [corrected]. Diabetes 57: 1254-1261, 2008. Erratum in: Diabetes 57: 2252, 2008
31. Lee EY, Chung CH, Khoury CC, Yeo TK, Pyagay PE, Wang A, Chen S: The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol 297: F85-F94, 2009
32. Wang S, Zhang M, Liang B, Xu J, Xie Z, Liu C, Viollet B, Yan D, Zou MH: AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: Role of 26S proteasomes. Circ Res 106: 1117-1128, 2010
33. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140: 95-107, 1992
34. Morse E, Schroth J, You YH, Pizzo DP, Okada S, Ramachandrarao S, Vallon V, Sharma K, Cunard R: TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1. Am J Physiol Renal Physiol 299: F965-F972, 2010
35. Kim HS, Lee G, John SW, Maeda N, Smithies O: Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration. Proc Natl Acad Sci U S A 99: 4602-4607, 2002 (Pubitemid 34286031)
36. RamachandraRao SP, Zhu Y, Ravasi T, McGowan TA, Toh I, Dunn SR, Okada S, Shaw MA, Sharma K: Pirfenidone is renoprotective in diabetic kidney disease. J Am Soc Nephrol 20: 1765-1775, 2009